Healthy
market conditions and a promising drug
future will almost gaurantee solid business
conditions for the sector. However, R&D,
Lifecycle Management, and Logistics effeciencies
must continue to be streamlined with stategy,
business, and technology solutions. Dynamic
international conditions are impacting
sourcing, manufacturing, and customer
markets. To remain competitive, the industry
is focusing on leveraging new markets
to offset increased risk from patent expirations
and overall competition. |
|